ARBUTUS
Live / Applied — Statement of use — non-final action mailed (as of 05 Nov 2025)
What this means for you
Not registered yet, but its 07 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98345817
- Mark type
- Stylized text
- Filed
- 07 Jan 2024
- Published for opposition
- 10 Sept 2024
- Attorney of record
- Sean P. Ritchie
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hepatitis
Owner
- Arbutus Biopharma Corporation, Warminster, PA, CA
- Arbutus Biopharma Corporation, Warminster, PA, CA
Prior registrations
Prosecution history
- 03 Feb 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 03 Feb 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 05 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Nov 2025 — NON-FINAL ACTION E-MAILED
- 05 Nov 2025 — SU - NON-FINAL ACTION - WRITTEN
- 02 Oct 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 05 May 2025 — USE AMENDMENT FILED
- 02 Oct 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 May 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 05 May 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 05 May 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 05 May 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 05 May 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 05 May 2025 — TEAS STATEMENT OF USE RECEIVED
- 05 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT